✦ LIBER ✦

PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011

✍ Scribed by Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Diana, C.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment of chronic myeloid

✍ Nicholas J. DiBella 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 108 KB

Dasatinib and nilotinib in first-line tr

✍ Jame Abraham 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 77 KB

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLE

✍ K El Ouagari; W Talbot; JF Baladi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN63 The Relative Value of Dasatinib Ve

✍ L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Utility Analysis of Dasatinib and N

✍ Kulpeng, Wantanee; Sompitak, Sumalai; Jootar, Saengsuree; Chansung, Kanchana; Te 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 433 KB